Krystal Biotech to Present at Cantor Global Healthcare Conference 2025

Company Participation - Krystal Biotech, Inc. will participate in the Cantor Global Healthcare Conference 2025 on September 4, 2025, in New York [1] - Krish S. Krishnan, Chairman and CEO, will engage in a fireside chat at 10:20 am ET and host investor meetings throughout the day [1] Webcast Information - A webcast of the presentation will be available starting at 10:20 am ET on September 4, 2025, and will be posted on the Company's website [2] Company Overview - Krystal Biotech, Inc. is a fully integrated, commercial-stage global biotechnology company focused on genetic medicines for diseases with high unmet medical needs [3] - The Company's first commercial product, VYJUVEK®, is the first-ever redosable gene therapy and the first genetic medicine approved in the US, Europe, and Japan for dystrophic epidermolysis bullosa [3] - The Company is advancing a robust pipeline of investigational genetic medicines in various fields including respiratory, oncology, dermatology, ophthalmology, and aesthetics [3]